Matsoukas, J

< Back to all Authors
Group by: Item type | Date
Number of items: 18.

Article

Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Bojarska, J, Chai, TT, Elnagdy, S, Kaczmarek, K, Matsoukas, J, Newton, R, Parang, K, Lopez, OP, Parhiz, H, Perera, CO, Pickholz, M, Remko, M, Saviano, M, Skwarczynski, M, Tang, Y, Wolf, WM, Yoshiya, T, Zabrocki, J, Zielenkiewicz, P, Alkhazindar, M, Barriga, Vanessa, Kelaidonis, K, Sarasia, EM and Toth, I (2021) A global review on short peptides: Frontiers and perspectives. Molecules, 26 (2). pp. 1-45. ISSN 1420-3049

Qaradakhi, Tawar, Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Matsoukas, J, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Zulli, Anthony ORCID: 0000-0002-2660-078X (2020) Could DIZE be the answer to COVID-19? Maturitas, 140. pp. 83-84. ISSN 0378-5122

Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Rostami, A and Matsoukas, J (2020) The Long Road of Immunotherapeutics against Multiple Sclerosis. Behavioral and Brain Sciences, 10 (5). ISSN 2076-3425

Matsoukas, J and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2020) New strategies in the immunotherapy of multiple sclerosis. Review of Clinical Pharmacology and Pharmacokinetics, International Edition, 34 (2). pp. 60-61. ISSN 1011-6583

Rodi, M, de Lastic, AL, Antonopoulou, S, Kylintireas, C, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Matsoukas, J and Mouzaki, A (2019) Antigen presentation by tolerogenic dendritic cells: the MOG35-55 -mannan conjugate paradigm. A potential therapeutic vaccine for Multiple Sclerosis. Review of Clinical Pharmacology and Pharmacokinetics, International Edition, 33 (3). pp. 92-93. ISSN 1011-6583

Lourbopoulos, A, Matsoukas, MT, Katsara, M, Deraos, G, Giannakopoulou, A, Lagoudaki, R, Grigoriadis, N, Matsoukas, J and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2018) Cyclization of PLP 139-151 peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitis. Bioorganic and Medicinal Chemistry, 26 (9). 2221 - 2228. ISSN 0968-0896

Michalatou, M, Androutsou, ME, Antonopoulos, M, Vlahakos, DV, Agelis, G, Zulli, Anthony ORCID: 0000-0002-2660-078X, Qaradakhi, T, Mikkelsen, Kathleen ORCID: 0000-0001-9166-4109, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Matsoukas, J (2018) Transdermal Delivery of AT1 Receptor Antagonists Reduce Blood Pressure and Reveal a Vasodilatory Effect on Kidney Blood Vessels. Current Molecular Pharmacology, 11 (3). 226 - 236. ISSN 1874-4672

Dargahi, Narges, Katsara, M, Tselios, T, Androutsou, ME, de Courten, Maximilian ORCID: 0000-0001-9997-9359, Matsoukas, J and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2017) Multiple sclerosis: Immunopathology and treatment update. Brain Sciences, 7 (7). ISSN 2076-3425

Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Deraos, G, Matsoukas, MT, Day, S, Stojanovska, Lily, Tselios, T, Androutsou, ME and Matsoukas, J (2017) Cyclic citrullinated MBP87–99 peptide stimulates T cell responses: Implications in triggering disease. Bioorganic and Medicinal Chemistry, 25 (2). 528 - 538. ISSN 0968-0896

Lourbopoulos, A, Deraos, G, Matsoukas, MT, Touloumi, O, Giannakopoulou, A, Kalbacher, H, Grigoriadis, N, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Matsoukas, J (2017) Cyclic MOG₃₅–₅₅ ameliorates clinical and neuropathological features of experimental autoimmune encephalomyelitis. Bioorganic and Medicinal Chemistry, 25 (15). 4163 - 4174. ISSN 0968-0896

Deraos, G, Rodi, M, Kalbacher, H, Chatzantoni, K, Karagiannis, F, Synodinos, L, Plotas, P, Papalois, A, Dimisianos, N, Papathanasopoulos, P, Gatos, D, Tselios, T, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Mouzaki, A and Matsoukas, J (2015) Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis. European Journal of Medicinal Chemistry, 101. 13 - 23. ISSN 0223-5234

Day, S, Tselios, T, Androutsou, ME, Tapeinou, A, Frilligou, I, Stojanovska, Lily, Matsoukas, J and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2015) Mannosylated linear and cyclic single amino acid mutant peptides using a small 10 amino acid linker constitute promising candidates against Multiple Sclerosis. Frontiers in Immunology, 6. ISSN 1664-3224

Tapeinou, A, Androutsou, ME, Kyrtata, K, Vlamis-Gardikas, A, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Matsoukas, J and Tselios, T (2015) Conjugation of a peptide to mannan and its confirmation by tricine sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Analytical Biochemistry, 485. 43 - 45. ISSN 0003-2697

Tseveleki, V, Tselios, T, Kanistras, I, Koutsoni, O, Karamita, M, Vamvakas, S-S, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Dotsika, E, Matsoukas, J, Lassmann, H and Probert, L (2014) Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis. Experimental Neurology, 267. 254 - 267. ISSN 0014-4886

Katsara, M, Deraos, S, Tselios, T, Pietersz, Geoff, Matsoukas, J and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2014) Immune responses of linear and cyclic PLP139-151 mutant peptides in SJL/J mice: peptides in their free state versus mannan conjugation. Immunotherapy, 6 (6). 709 - 724. ISSN 1750-743X

Laimou, D, Lazoura, E, Troganis, AN, Matsoukas, MT, Deraos, SN, Katsara, M, Matsoukas, J, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Tselios, T (2011) Conformational studies of immunodominant myelin basic protein 1-11 analogues using NMR and molecular modeling. Journal of Computer - Aided Molecular Design, 25 (11). 1019 - 1032. ISSN 0920-654X

Katsara, M, Yuriev, E, Ramsland, PA, Deraos, G, Tselios, T, Matsoukas, J and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2008) Mannosylation of mutated MBP83-99 peptides diverts immune responses from Th1 to Th2. Molecular Immunology, 45 (13). 3661 - 3670. ISSN 0161-5890

Conference or Workshop Item

Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Katsara, M, Day, S, Tselios, T and Matsoukas, J (2012) Immunotherapeutic aspects for MS: are we heading in the right direction? In: Progress in MS Research Conference 2011, 26 October 2011-28 October 2011, Melbourne, Australia.